AbbVie Inc. (ABBV) Earnings
AbbVie Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Jul 31, 2026
From the latest earnings 8-K
Revenue · FY2025
$61.16B
▲ 8.6%YoY
Diluted EPS · FY2025
$2.36
▼ 1.3%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from ABBV's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS |
|---|---|---|---|---|
| FY2025 | $61.16B | $4.23B | — | $2.36 |
| FY2024 | $56.33B | $4.29B | — | $2.39 |
| FY2023 | $54.32B | $4.87B | — | $2.72 |
| FY2022 | $58.05B | $11.85B | — | $6.63 |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Jul 31, 2026 | 8-K (2.02) | 0001551152-26-000023EDGAR |
| Jul 6, 2026 | 8-K (2.02) | 0001551152-26-000021EDGAR |
| Apr 29, 2026 | 8-K (2.02) | 0001551152-26-000013EDGAR |
| Apr 3, 2026 | 8-K (2.02) | 0001551152-26-000011EDGAR |
| Feb 4, 2026 | 8-K (2.02) | 0001551152-26-000004EDGAR |
| Jan 7, 2026 | 8-K (2.02) | 0001551152-26-000002EDGAR |
| Oct 31, 2025 | 8-K (2.02) | 0001551152-25-000047EDGAR |
| Oct 3, 2025 | 8-K (2.02) | 0001551152-25-000043EDGAR |
Earnings for companies related to ABBV
Never miss a ABBV filing.
Get an email when ABBV files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.